Hany Elmariah, MD, discussed the safety profile of fedratinib and its evolving role in the post-transplant setting for patients with myeloproliferative neoplasms.

Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based ...

Vyne Therapeutics has dosed the first participant in a randomised Phase Ib clinical trial of VYN202, an oral treatment for ...

Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...

Adolescents in the United States with symptoms of ADHD had a higher likelihood of using tobacco and other nicotine-based products, results from a cohort study published in JAMA Network Open ...

It started with a bit of flirting, progressed to phone sex and love letters, and then developed into a full-blown romance ...

It started with a bit of flirting, progressed to phone sex and love letters, and then developed into a full-blown romance ...

Lighthouse Autism Center is proud to announce the expansion of its diagnostic testing services, offering more appointments ...

Studies from Munich University highlighted quality of life in bladder and prostate cancer at ASCO 2025 Genitourinary Cancers ...

Kaitlyn Bristowe opened up about her past mental health struggles and how a Care Bear gifted by her stepdad helped get her ...

Telix is in a strong financial position with net cash of AUD 140 million as of December 2024. We forecast free cash flow averaging 87% of net income over the next 10 years, and in the absence of major ...

Regenerative Medicine Advanced Therapy (RMAT) designation follows Phase Ib 36-month data Study demonstrated favorable safety profile and continued positive trends in assessed clinical outcome measures ...